{
    "organizations": [],
    "uuid": "d5337abcd3fc290b3f0e0bc729c60d82d40d0d63",
    "author": "",
    "url": "https://www.reuters.com/article/brief-apricus-biosciences-announces-outc/brief-apricus-biosciences-announces-outcome-of-vitaros-end-of-review-meeting-with-fda-idUSFWN1RT09W",
    "ord_in_thread": 0,
    "title": "BRIEF-Apricus Biosciences Announces Outcome Of Vitaros™ End-Of-Review Meeting With FDA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 06 AM / Updated 10 minutes ago BRIEF-Apricus Biosciences Announces Outcome Of Vitaros™ End-Of-Review Meeting With FDA Reuters Staff \nApril 16 (Reuters) - Apricus Biosciences Inc: \n* APRICUS BIOSCIENCES ANNOUNCES OUTCOME OF VITAROS™ END-OF-REVIEW MEETING WITH FDA \n* APRICUS BIOSCIENCES INC - COMPANY EVALUATING STRATEGIC ALTERNATIVES \n* APRICUS BIOSCIENCES INC - COMPANY SEEKING PARTNER TO DEVELOP VITAROS IN U.S. \n* APRICUS BIOSCIENCES INC - FDA CONFIRMED DURING MEETING THAT COMPANY SHOULD DEVELOP A NEW VITAROS FORMULATION \n* APRICUS - PRELIMINARY END-OF-REVIEW MEETING MINUTES SUPPORT PLAN TO ADDRESS ISSUES CITED BY FDA IN ITS FEB 15 CRL FOR VITAROS NDA \n* APRICUS BIOSCIENCES - FDA ALSO CONFIRMED 2 NEW PHASE 3 CLINICAL EFFICACY TRIALS WITH REFORMULATED PRODUCT SHOULD BE CONDUCTED PRIOR TO RESUBMITTING NDA \n* APRICUS - IN ADDITION, FDA REQUESTED CERTAIN PHARMACOKINETIC ASSESSMENTS THAT CO EXPECTS CAN BE COMPLETED AS PART OF REQUESTED PHASE 3 PROGRAM \n* APRICUS BIOSCIENCES- FDA SAID CHEMISTRY, MANUFACTURING AND CONTROL SECTION IN RESUBMISSION TO BE UPDATED WITH DATA FROM DEVELOPMENT OF NEW FORMULATION \n* APRICUS - INITIATED DISCUSSIONS WITH INTERESTED PARTIES FOR U.S. VITAROS RIGHTS FOR FINANCIAL TERMS COMMENSURATE WITH DEVELOPMENT STAGE ASSET Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)",
    "published": "2018-04-16T14:04:00.000+03:00",
    "crawled": "2018-04-16T14:21:15.012+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "updated",
        "minute",
        "ago",
        "bioscience",
        "announces",
        "outcome",
        "meeting",
        "fda",
        "reuters",
        "staff",
        "april",
        "reuters",
        "apricus",
        "bioscience",
        "inc",
        "apricus",
        "bioscience",
        "announces",
        "outcome",
        "meeting",
        "fda",
        "apricus",
        "bioscience",
        "inc",
        "company",
        "evaluating",
        "strategic",
        "alternative",
        "apricus",
        "bioscience",
        "inc",
        "company",
        "seeking",
        "partner",
        "develop",
        "vitaros",
        "apricus",
        "bioscience",
        "inc",
        "fda",
        "confirmed",
        "meeting",
        "company",
        "develop",
        "new",
        "vitaros",
        "formulation",
        "apricus",
        "preliminary",
        "meeting",
        "minute",
        "support",
        "plan",
        "address",
        "issue",
        "cited",
        "fda",
        "feb",
        "crl",
        "vitaros",
        "nda",
        "apricus",
        "bioscience",
        "fda",
        "also",
        "confirmed",
        "new",
        "phase",
        "clinical",
        "efficacy",
        "trial",
        "reformulated",
        "product",
        "conducted",
        "prior",
        "resubmitting",
        "nda",
        "apricus",
        "addition",
        "fda",
        "requested",
        "certain",
        "pharmacokinetic",
        "assessment",
        "co",
        "expects",
        "completed",
        "part",
        "requested",
        "phase",
        "program",
        "apricus",
        "fda",
        "said",
        "chemistry",
        "manufacturing",
        "control",
        "section",
        "resubmission",
        "updated",
        "data",
        "development",
        "new",
        "formulation",
        "apricus",
        "initiated",
        "discussion",
        "interested",
        "party",
        "vitaros",
        "right",
        "financial",
        "term",
        "commensurate",
        "development",
        "stage",
        "asset",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}